# Sense of Coherence in the Trauma–Fibromyalgia Relationship: Mediation and Moderation Findings from a 2099-Participant Cohort

**Authors:** Wolnei Caumo, Graziele Borges Bueno, Giordano Mayer De Freitas, Guilherme Teixeira Lopes, Mariana Lentino Coelho, Julia Gomes, Caroline Leffa Venturini, Maria Eduarda Louzada, Sara Machado Peres, Iraci L. S. Torres, Andrea Cristiane Janz Moreira, Felipe Fregni

PMC · DOI: 10.3390/ejihpe16030045 · European Journal of Investigation in Health, Psychology and Education · 2026-03-23

## TL;DR

This study shows that a person's sense of coherence helps explain how trauma relates to fibromyalgia symptoms and can reduce their impact.

## Contribution

The study identifies sense of coherence as a key mediator and moderator in trauma-FM symptom relationships using a large cohort.

## Key findings

- Higher adversity predicts lower sense of coherence, which in turn predicts higher symptom burden.
- Sense of coherence weakens the effects of trauma on fatigue and global impact in fibromyalgia.
- Comorbidities like hypertension and stroke have smaller effects compared to sense of coherence.

## Abstract

Background: The biopsychosocial model positions fibromyalgia (FM) as the result of altered pain modulation shaped by trauma, psychological vulnerability, and structural stressors. The Sense of Coherence (SOC) may be a key resilience factor explaining differences in symptom severity after similar hardships. Objectives: To evaluate whether SOC mediates and/or moderates associations between trauma-related adversity and symptom burden in FM and whether comorbidities, medication use, healthcare factors, or treatment engagement modify these relationships. Methods: In this cross-sectional study, 2099 women with FM completed an online survey assessing adversity, psychosocial factors, core symptoms, healthcare support, treatment engagement, and medication use. A theory-driven SOC composite followed Antonovsky’s model (comprehensibility, manageability, meaningfulness) using the proxy SOC composite derived from a theory-driven framework that underwent internal construct validation, including discriminant validity analyses and latent structure evaluation, but it was not benchmarked against a gold-standard SOC questionnaire. Linear regression evaluated adversity–symptom associations, SOC mediation, and moderation by SOC and medication classes. Results: Higher adversity predicted lower SOC (e.g., cumulative abuse: B = −0.25), and lower SOC predicted higher symptom burden (e.g., Fibromyalgia Impact Questionnaire (FIQ): B = −6.77), producing significant indirect effects (cognitive symptoms: 0.22; FIQ: 1.69). SOC also moderated the effects of adversity on fatigue and global impact, weakening associations at higher SOC. Comorbidities showed modest influence: hypertension had minor indirect effects (ab = 0.27), scheduled consultation produced small interactions (cognition β = −0.38 to −0.46; fatigue β = ~0.05–0.06), and stroke showed the only clinically meaningful moderation (β ≈ 4.9–5.2), all far smaller than SOC effects. Conclusions: SOC functions as a central psychosocial pathway and resilience-related factor in the association between trauma and FM symptoms. Targeting SOC-related processes may help reduce symptom burden and improve outcomes.

## Linked entities

- **Diseases:** fibromyalgia (MONDO:0005546), stroke (MONDO:0005098)

## Full-text entities

- **Genes:** UBXN11 (UBX domain protein 11) [NCBI Gene 91544] {aka COA-1, PP2243, SOC, SOCI, UBXD5}
- **Diseases:** musculoskeletal pain (MESH:D059352), PTSD (MESH:D013313), chronic illness (MESH:D002908), aggression (MESH:D010554), bipolar disorder (MESH:D001714), pain conditions (MESH:D013001), Symptom (MESH:D012816), hypertension (MESH:D006973), urological complaints (MESH:D014570), chronic pain (MESH:D059350), Fatigue (MESH:D005221), autonomic (MESH:D001342), anxiety (MESH:D001007), sexual abuse (MESH:D000082002), inflammation (MESH:D007249), work (MESH:D000073397), inflammatory bowel disease (MESH:D015212), HPA axis (MESH:C566610), stroke (MESH:D020521), impairment (MESH:D060825), neuropathic pain (MESH:D009437), Trauma (MESH:D014947), Depressive symptoms (MESH:D003866), impaired quality of life (MESH:D003643), panic disorder (MESH:D016584), endometriosis (MESH:D004715), Alcohol Use Disorders (MESH:D000437), FM (MESH:D005356), Pain (MESH:D010146), Cognitive symptoms (MESH:D019954), depressive psychiatric (MESH:D001523), anxiety disorders (MESH:D001008), rumination (MESH:D000079562), abuse (MESH:D019966), sleep disturbances (MESH:D012893), sexual violence (MESH:D050035), cognitive (MESH:D003072), emotional distress (MESH:D012128), gynecological disease (MESH:D005831), diabetes (MESH:D003920), headaches (MESH:D006261)
- **Chemicals:** morphine (MESH:D009020), oxycodone (MESH:D010098), dyclonine (MESH:C100063), melatonin (MESH:D008550), Zolpidem (MESH:D000077334), acetaminophen (MESH:D000082), methadone (MESH:D008691), dyprinon (-), tramadol (MESH:D014147), codeine (MESH:D003061), Alcohol (MESH:D000438), benzodiazepines (MESH:D001569)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13025946/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025946/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC13025946/full.md

---
Source: https://tomesphere.com/paper/PMC13025946